Hims & Hers Health is trading 3.6% up at €23.28 today, rebounding from yesterday's sharp decline.
- The stock fell 10.51% to €22.48 yesterday following the announcement of an FTC lawsuit against the telehealth provider.
- The lawsuit alleges Hims & Hers misled consumers, obstructed cancellations, and illegally shared patient data.
- Today's movement appears to be a partial recovery from the significant company-specific legal shock.